EVALUATION OF SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF MEDI1814, A BETA-AMYLOID 42 (Aβ42)-SPECIFIC ANTIBODY, IN PATIENTS WITH MILD-MODERATE ALZHEIMER'S DISEASE
Ostenfeld, Thor, Pomfret, Michael, Billinton, Andy, Chessell, Iain, Chessell, Tharani, Lindqvist, Eva, Valencia, Zulma Santisteban, Groves, Maria, Narwal, Rajesh, Tatipalli, Manasa, Lee, Nancy, TurnerVolume:
13
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2017.07.193
Date:
July, 2017
File:
PDF, 221 KB
english, 2017